A novel tandem repeat sequence mutation occurring in NRAS was identified in a patient with unclassified MDS/MPN was tested in zebrafish, resulting in marrow proliferation phenotypes reversed by MEK inhibition [91]. This evidence concerns the gene NRAS and myelodysplastic syndrome.